FIRM FIXED PRICE
ADVANCED ACCELERATOR APPLICATIONS USA INC - LUTATHERA (LUTETIUM LU 177 DOTATATE) 3 DOSES
PIID: 36C25023F0658
Signed Date: Feb 27, 2026Effective Date: May 2, 2023End Date: Closed on Oct 31, 2023
Key Details
Description
LUTATHERA (LUTETIUM LU 177 DOTATATE) 3 DOSES
Contractor Information
Contractor: ADVANCED ACCELERATOR APPLICATIONS USA INC
UEI: JNM4NBNHFE66
CAGE Code: 3PTH3
Location: NEW YORK, NY
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.